專技 - 藥物治療學題庫下載題庫

2023年GOLD guideline搭配UpToDate

initial

Group A: Less symptomatic, low risk of future exacerbations

•mMRC grade 0 to 1 or CAT score <10

•Zero to one exacerbation per year without hospitalization

1. LAMA(首選)或LABA

2. SABA或SAMA

Group B: More symptomatic, low risk of future exacerbations

•mMRC grade ≥2 or CAT score ≥10

•Zero to one exacerbation per year without hospitalization

LAMA加LABA

Group E: High risk of future exacerbations •≥2 exacerbations per year or ≥1 hospitalization for exacerbation

1. LAMA加LABA(首選)

2. 如果eos ≥ 300 cells/µl，使用LABA+LAMA+ICS

 

follow ...

查看完整內容

2023年GOLD guideline搭配UpToDate

initial

Group A: Less symptomatic, low risk of future exacerbations	•mMRC grade 0 to 1 or CAT score <10 •Zero to one exacerbation per year without hospitalization	1. LAMA(首選)或LABA 2. SABA或SAMA
Group B: More symptomatic, low risk of future exacerbations	•mMRC grade ≥2 or CAT score ≥10 •Zero to one exacerbation per year without hospitalization	LAMA加LABA
Group E: High risk of future exacerbations	•≥2 exacerbations per year or ≥1 hospitalization for exacerbation	1. LAMA加LABA(首選) 2. 如果eos ≥ 300 cells/µl，使用LABA+LAMA+ICS

 

follow up

但我不知道這題的stage 2是屬於哪個類別，但COPD的人建議可以打肺炎疫苗，就先選肺炎疫苗了。